NL FR EN
www.belgium.be

PROJECT KU Leuven-eda727e7-ac4c-422b-9c0b-c71543d76c5c

Source DBnl 
InstitutionKU Leuven 
Codeeda727e7-ac4c-422b-9c0b-c71543d76c5c 
Unitbd5a9007-405a-4a9e-90f5-c218b16ae8f2
Begin1/1/2018
End12/31/2021
title fr
title nlActief microvasculaire regressie drijft diastolisch hartfalen
title enActive microvascular regression drives diastolic dysfunction leading to heart failure
Description fr
Description nlDit onderzoek vertegenwoordigt een nieuw perspectief op HFpEF, waarbij de nadruk ligt op de disfunctie van bloedvaten in plaats van de disfunctie van de hartspiercellen, en onderzoekt ook waarom een verlaagde dichtheid van de bloedvaten optreedt.
Description enHeart disease is the most important cause of mortality in westernized nations, with heart failure, which is when the heart cannot pump sufficient blood, being the most prominent cause of hospitalizations in Europe. More than half of the heart failure patients have heart failure with preserved ejection fraction (HFpEF). HFpEF occurs in patients that present with additional disorders such as diabetes and hypertension. There is currently no successful treatment for HFpEF. There is increasing evidence that the blood vessels that feed the heart tissue are dysfunctional during HFpEF and we have preliminary results showing that a reduction in blood vessel density is present in HFpEF. We also have gene analysis data showing that a gene, called Pitx2, is downregulated. This is important because in other model, Pitx2 downregulation drives vessels to regress. We will therefore investigate Pitx2 regulation in various models of heart failure, including biopsie samples from people who suffer from heart failure. This research represents a new perspective on HFpEF, focusing on blood vessel dysfunction rather than heart muscle cell dysfunction, as well as investigating why reduced blood vessel density occurs.
Qualifiers - Blood vessel density - Blood vessel dysfunction - HFpEF - Pitx2 -
PersonalJones Elizabeth 
Collaborations